Verified employee & interview reviews

Aragen Life Sciences Reviews

Hyderabad, Telangana

—/ 5

0 reviews

Aragen Life Sciences Limited, formerly known as GVK Biosciences Private Limited, is a globally renowned Contract Research, Development, and Manufacturing Organization (CRDMO) headquartered in Hyderabad, Telangana, India. Founded in December 2000, the company rebranded to Aragen Life Sciences in 2021 to mark its 20-year milestone and its comprehensive transformation into a specialized R&D and manufacturing partner for the global life sciences sector. Operating under a "services-only" business model, Aragen functions as a pure-play service provider. It maintains no internal drug discovery programs or stakes in the intellectual property of other firms, ensuring it collaborates rather than competes with its client base. The company provides end-to-end integrated and standalone solutions across the entire drug discovery, development, and manufacturing continuum. Its core competencies support both small molecules and biologics, assisting large pharmaceutical corporations, biotechnology entities, agrochemical firms, animal health operations, and performance chemical organizations worldwide. Structurally, Aragen distributes its capabilities across several major business verticals, including Discovery Services, Chemistry Services, Biology Services, Drug Repurposing, Chemical Development, and Contract Manufacturing. Its comprehensive offerings feature antibody discovery, cell line development, pre-clinical efficacy studies, process validation, formulation R&D, and the commercial supply of Active Pharmaceutical Ingredients (APIs) and advanced intermediates. The company maintains a significant global footprint with infrastructure spanning India and the United States. Aragen operates multiple technologically advanced facilities covering over 1.2 million square feet. This network includes chemistry, biology, and analytical laboratories, AAALAC-accredited animal houses, kilo labs, pilot plants, and large-scale manufacturing infrastructure. Notably, the company expanded its operations by establishing a Biologics Cell Culture development and manufacturing facility in Bengaluru, India. Aragen's facilities conform to stringent international regulatory standards and have been successfully inspected by leading global agencies, including the USFDA, WHO, PMDA, EDQM, and EMEA. Led by Chairman Davinder Singh Brar, Discovery Solutions CEO Neeraj Garg, and Dr. Subodh Deshmukh (CEO of Aragen Bioscience), Aragen utilizes proprietary project management systems, such as its "XLRATE" platform, to manage timelines and maintain a customer repeat rate exceeding 90%. Financially, as a private limited entity, Aragen generated more than INR 1,000 crore in revenue for the financial year ending March 31, 2025. Backed by major investors including Goldman Sachs Asset Management and Quadria Capital, the company employs a workforce of approximately 5,000 individuals, featuring a dominant scientific talent pool of over 2,800 scientists and 450+ PhDs. Furthermore, Aragen emphasizes corporate sustainability and worker culture, having secured a Platinum Medal rating from EcoVadis—placing it in the top 1% of evaluated companies globally—alongside a multi-year Great Place to Work certification.